Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 18, 2022
[ Fri, Nov 18th 2022
] - WOPRAI
[ Fri, Nov 18th 2022
] - WOPRAI
[ Fri, Nov 18th 2022
] - WOPRAI
[ Fri, Nov 18th 2022
] - WOPRAI
[ Fri, Nov 18th 2022
] - WOPRAI
[ Fri, Nov 18th 2022
] - WOPRAI
[ Fri, Nov 18th 2022
] - WOPRAI
[ Fri, Nov 18th 2022
] - WOPRAI
[ Fri, Nov 18th 2022
] - WOPRAI
[ Fri, Nov 18th 2022
] - WOPRAI
[ Fri, Nov 18th 2022
] - WOPRAI
[ Fri, Nov 18th 2022
] - WOPRAI
[ Fri, Nov 18th 2022
] - WOPRAI
[ Fri, Nov 18th 2022
] - WOPRAI
Thu, November 17, 2022
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
Paul Gong Upgraded (XPEV) to Strong Buy and Decreased Target to $13 on, Nov 17th, 2022
Paul Gong of UBS, Upgraded "XPeng Inc." (XPEV) to Strong Buy and Decreased Target from $34 to $13 on, Nov 17th, 2022.
Paul has made no other calls on XPEV in the last 4 months.
There are 3 other peers that have a rating on XPEV. Out of the 3 peers that are also analyzing XPEV, 2 agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jiong Shao of "Barclays" Maintained at Hold with Decreased Target to $8 on, Friday, October 28th, 2022
- Erica Chen of "Macquarie" Downgraded from Buy to Hold and Held Target at $25 on, Wednesday, August 3rd, 2022
This is the rating of the analyst that currently disagrees with Paul
- Jeff Chung of "Citigroup" Downgraded from Strong Buy to Strong Sell and Held Target at $3.18 on, Friday, October 28th, 2022
